Clinical Trial Update: An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease

View source ↗

Summary

An open-label, observational long-term follow-up study evaluating the safety and efficacy of RGL-193 Putamen Injection in patients with Parkinson's disease; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RGL-193 Putamen Injection (RGL-193)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Parkinson's Disease | Status: NOT_YET_RECRUITING